PriceTargets.com logo

Microbot Medical - MBOT Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $8.00
  • Forecasted Upside: 268.66%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$2.17 As of 06/2/2023 11:09 AM ET
▲ +0.01 (0.46%)

This chart shows the closing price for MBOT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Microbot Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MBOT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MBOT

Analyst Price Target is $8.00
▲ +268.66% Upside Potential
This price target is based on 0 analysts offering 12 month price targets for Microbot Medical in the last 3 months. The average price target is $8.00, with a high forecast of $8.00 and a low forecast of $8.00. The average price target represents a 268.66% upside from the last price of $2.17.

This chart shows the closing price for MBOT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Microbot Medical. This rating has held steady since August 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/4/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/2/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/8/2023HC WainwrightLower Target$20.00 ➝ $8.00Low
8/18/2020HC WainwrightBoost TargetPositive ➝ Buy$19.00 ➝ $20.00Medium
5/20/2020HC WainwrightReiterated RatingBuy$19.00Low
5/1/2020HC WainwrightReiterated RatingBuy$26.00 ➝ $19.00Low
1/13/2020HC WainwrightBoost TargetBuy$12.00 ➝ $26.00High
12/24/2019HC WainwrightReiterated RatingPositive ➝ Buy$10.00 ➝ $12.00High
11/22/2019HC WainwrightReiterated RatingBuy$10.00Low
9/11/2019HC WainwrightReiterated RatingBuy$10.00Medium
8/21/2019HC WainwrightReiterated RatingBuy$10.00Low
7/22/2019HC WainwrightInitiated CoverageBuy$10.00High
11/19/2018LADENBURG THALM/SH SHDowngradeBuy ➝ Hold$1.75High
(Data available from 6/2/2018 forward)

News Sentiment Rating

0.84 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2022
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/3/2023
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/2/2023
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2023
  • 4 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2023
  • 11 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2023

Current Sentiment

  • 11 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Microbot Medical logo
Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
Read More

Today's Range

Now: $2.17
Low: $2.12
High: $2.27

50 Day Range

MA: $1.72
Low: $1.06
High: $3.19

52 Week Range

Now: $2.17
Low: $1.00
High: $6.33

Volume

1,264,926 shs

Average Volume

2,165,020 shs

Market Capitalization

$17.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.12

Frequently Asked Questions

What sell-side analysts currently cover shares of Microbot Medical?

The following Wall Street analysts have issued stock ratings on Microbot Medical in the last twelve months: HC Wainwright.
View the latest analyst ratings for MBOT.

What is the current price target for Microbot Medical?

1 Wall Street analysts have set twelve-month price targets for Microbot Medical in the last year. Their average twelve-month price target is $8.00, suggesting a possible upside of 268.7%. HC Wainwright has the highest price target set, predicting MBOT will reach $8.00 in the next twelve months. HC Wainwright has the lowest price target set, forecasting a price of $8.00 for Microbot Medical in the next year.
View the latest price targets for MBOT.

What is the current consensus analyst rating for Microbot Medical?

Microbot Medical currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MBOT.

What other companies compete with Microbot Medical?

Other companies that are similar to Microbot Medical include Surrozen, Genetic Technologies, SQZ Biotechnologies, Peak Bio and Organovo. Learn More about companies similar to Microbot Medical.

How do I contact Microbot Medical's investor relations team?

Microbot Medical's physical mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company's listed phone number is (781) 875-3605 and its investor relations email address is mpoly[email protected]. The official website for Microbot Medical is www.microbotmedical.com. Learn More about contacing Microbot Medical investor relations.